ArticleBMJ open2022

PCSK9 inhibition in patients with acute stroke and symptomatic intracranial atherosclerosis: protocol for a prospective, randomised, open-label, blinded end-point trial with vessel-wall MR imaging.

Yen-Chu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.